Comments
Loading...
Macrogenics (MGNX) Forecast
NewsEarningsMacrogenics (MGNX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestMacrogenics (NASDAQ:MGNX) Stock Quotes, Forecast and News Summary
Macrogenics Stock (NASDAQ: MGNX) stock price, news, charts, stock research, profile.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Macrogenics (MGNX) stock?
You can purchase shares of Macrogenics (NASDAQ:MGNX) through any online brokerage.
Who are Macrogenics (MGNX) competitors?
Other companies in Macrogenics’s space includes: Molecular Partners (NASDAQ:MOLN), Precigen (NASDAQ:PGEN), Zentalis Pharma (NASDAQ:ZNTL), Inozyme Pharma (NASDAQ:INZY) and Fate Therapeutics (NASDAQ:FATE).
What is the forecast, or price target, for Macrogenics (MGNX) stock?
Macrogenics has a consensus price target of $12.40.
What is the current price for Macrogenics (MGNX)?
The stock price for Macrogenics (NASDAQ: MGNX) is $3.25 last updated December 23, 2024 at 12:45 PM EST.
Does Macrogenics (MGNX) pay a dividend?
There are no upcoming dividends for Macrogenics.
When is Macrogenics (NASDAQ:MGNX) reporting earnings?
Macrogenics’s Q4 earnings are confirmed for Thursday, March 6, 2025.
Is Macrogenics (MGNX) going to split?
There is no upcoming split for Macrogenics.
What sector and industry does Macrogenics (MGNX) operate in?
Macrogenics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.